Tempus AI
Tempus AI Inc is an American healthcare technology company applying artificial intelligence and precision medicine to precision diagnostics. The company operates a proprietary data technology platform that analyzes genomic sequencing, clinical records, and pathology data to assist physicians in personalized patient care. Main revenue drivers include genomic sequencing diagnostic fees, clinical data licensing fees to pharmaceutical partners, and AI application subscriptions. Tempus AI serves oncologists, clinical research networks, academic medical centers, and biopharmaceutical development companies across North America. The company holds a pioneer position in multi-modal clinical and genomic data aggregation for precision oncology. Headquartered in Chicago, Illinois, Tempus AI Inc is listed on the Nasdaq Stock Market.
9 of the funds FundTelligence covers report a position in Tempus AI.
- Legal name
- Tempus AI Inc
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 9
- Exposure themes
- Cancer Profiling, Molecular Diagnostics, Precision Medicine & Genomics, Artificial Intelligence, Clinical Data & Precision Medicine, Digital Transformation, Healthcare, Technology Themes
Funds holding Tempus AI
- DNB Fund Disruptive Opportunities — DNB · 3.93 % (full portfolio disclosed, September 2026)
- DNB Fund Future Waves — DNB · 2.73 % (full portfolio disclosed, August 2026)
- Franklin Technology Fund — Franklin Templeton · 1.15 % (full portfolio disclosed, September 2026)
- BlackRock iShares NASDAQ US Biotechnology UCITS ETF — BlackRock · 0.86 % (full portfolio disclosed, October 2026)
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.8 % (full portfolio disclosed, October 2026)
- Franklin U.S. Opportunities Fund — Franklin Templeton · 0.39 % (full portfolio disclosed, September 2026)
- Franklin US Opportunities — Franklin Templeton · 0.39 % (full portfolio disclosed, September 2026)
- DNB Global Enhanced Small Cap — DNB · 0.09 % (full portfolio disclosed, September 2026)
Showing the 8 largest of 9 funds holding it.